Stock daily read

What happened with INGN today?

Why it moved
Explains possible causes using the day’s news and filings
Moving with the market?
Uses market moves and trading volume to assess what drove the change
What to watch next
The next thing that could change the call, and what to look for

No read yet

Uses news and trading volume to explain the day’s move and how it relates to the market.

Investment outlook

INGN in three months: buy, wait or sell?

Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.

In the report
  • Buy / Wait / Sell rating
  • 3-month target price
  • Bear · Base · Bull
  • vs. the market

Company

Company overview

Inogen Inc serves patients who need supplemental oxygen over the long term. Its Inogen One and Inogen Rove portable systems concentrate oxygen from surrounding air and deliver it as patients inhale. Equipment sales provide most of its revenue. Home medical equipment providers, distributors and resellers buy its products, while patients can also buy directly in the United States. Outside the United States, Inogen bills distributors and large provider accounts, which handle patient billing and care locally.

Inogen also rents equipment directly to U.S. patients using insurance benefits. It checks coverage, obtains physician paperwork and bills Medicare, private insurers and patients. Medicare supplies most rental revenue, so coverage rules and reimbursement rates matter to this part of the business. Medicare stops regular equipment rental payments before the supplier’s service obligation ends, leaving Inogen responsible for continued oxygen service and equipment upkeep without further equipment rental payments during that period.

A small group of customers contributes a substantial share of revenue, including one particularly large customer. Direct Medicare rentals also require supplier approval, independent accreditation and state licensing; Inogen cannot simply sell a device and bill Medicare without meeting those requirements.

Read allShow less
Source: SEC filing

Red flags

Know what’s buried in INGN’s filings before you buy

The risk section is the longest, dullest part of the filing. This keeps only what can really hurt you: where it hits, how hard, when it plays out.

Sorted into
  • Happening now
  • Could go wrong
  • Built in

Moat

INGN says it has a moat. Does it hold up?

Every company claims an edge. Each one is checked against hard numbers like margins and returns: which hold, and which line gives way first.

Each edge rated
  • Strong
  • Moderate
  • Limited
  • Unproven

Related companies

  • Competition
  • Shared drivers
  • Supplier
  • Customer

Inogen’s results depend on home oxygen demand, provider purchasing and reimbursement, while its Yuwell collaboration brings new respiratory products and expands Asia-Pacific distribution.

  • AdaptHealth Corp. supplies home oxygen equipment and ongoing respiratory care to patients who could instead rent oxygen systems directly from Inogen. Watch its Respiratory Health business for signs of demand among the home oxygen patients both companies serve.

  • Viemed Healthcare, Inc. competes with Inogen for home respiratory patients and physician referrals, providing home oxygen therapy and earning respiratory-equipment revenue mainly through monthly rentals. Its oxygen-therapy news is more directly relevant to Inogen’s oxygen-system business than its broader respiratory revenue, which also includes home ventilation.

Agenda

in 13 daysTue, Nov 3

  1. Time to be announced

    AdaptHealth Corp. earningsAHCO

    AdaptHealth Corp. serves home-oxygen patients through its Respiratory Health business, and its report will show whether demand among those patients is holding up in a market where some could rent equipment directly from Inogen.

in 14 daysWed, Nov 4

  1. Time to be announced

    Viemed Healthcare, Inc. earningsVMD

    Viemed Healthcare, Inc. mainly earns respiratory-equipment revenue from rentals and competes with Inogen for home-oxygen patients and physician referrals, so its report will show whether their overlapping oxygen business is strengthening or softening.

in 15 daysThu, Nov 5

  1. Time to be announced
    Major

    Inogen Inc earningsThis company

    Inogen sells oxygen equipment and rents it directly to patients, and this report will show whether both streams support the business without manufacturing and service costs eating away at the economics.